Skip to Content

Gerresheimer AG GRRMF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Gerresheimer AG provides specialty glass and plastic products to the pharmaceutical and healthcare industry. The firm operates in three segments: plastics and devices, primary packaging glass and advanced technologies. The plastics and devices segment sells products for drug administration, including insulin pens, inhalers, prefillable syringes, and plastic packaging for medications. The primary packaging glass segment produces glass packaging products for drugs and cosmetics, such as injection vials, cartridges, and jars. The advanced technologies segment develops and manufactures intelligent drug delivery systems. Gerresheimer generates the majority of its revenue in Europe, with sales in Germany contributing the largest proportion of any country.

Contact
Klaus-Bungert-Strasse 4
Duesseldorf, NW, 40468, Germany
T +49 211618100
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings Nov 30, 2020
Fiscal Year End Nov 30, 2021
Stock Type
Employees 9,882